# A Study to Determine the Pharmacokinetic Profile, Safety and Tolerability of Sildenafil (REVATIO®) in Cardiac Surgery

> **NCT02136329** · PHASE1 · COMPLETED · sponsor: **University of Leicester** · enrollment: 36 (actual)

## Conditions studied

- Acute Kidney Injury

## Interventions

- **DRUG:** Sildenafil

## Key facts

- **NCT ID:** NCT02136329
- **Lead sponsor:** University of Leicester
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2020-01-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02136329

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02136329, "A Study to Determine the Pharmacokinetic Profile, Safety and Tolerability of Sildenafil (REVATIO®) in Cardiac Surgery". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02136329. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*